• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Efficacy and safety of axitinib for metastatic renal cell carcinoma in patients on hemodialysis for end-stage renal disease: Case series of eight patients.

作者信息

Ishihara Hiroki, Takagi Toshio, Kondo Tsunenori, Yoshida Kazuhiko, Okumi Masayoshi, Tanabe Kazunari

机构信息

Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.

Department of Urology, Tokyo Women's Medical University Medical Center East, Tokyo, Japan.

出版信息

Int J Urol. 2019 Nov;26(11):1081-1082. doi: 10.1111/iju.14093. Epub 2019 Aug 25.

DOI:10.1111/iju.14093
PMID:31448432
Abstract
摘要

相似文献

1
Efficacy and safety of axitinib for metastatic renal cell carcinoma in patients on hemodialysis for end-stage renal disease: Case series of eight patients.阿昔替尼用于终末期肾病血液透析患者转移性肾细胞癌的疗效和安全性：8例患者的病例系列
Int J Urol. 2019 Nov;26(11):1081-1082. doi: 10.1111/iju.14093. Epub 2019 Aug 25.
2
Avelumab plus Axitinib for the Treatment of Patients with End-Stage Renal Disease Undergoing Dialysis: A Retrospective Case Series and Literature Review.阿维鲁单抗联合阿昔替尼治疗透析终末期肾病患者：回顾性病例系列及文献复习。
Urol Int. 2023;107(3):321-326. doi: 10.1159/000528447. Epub 2023 Feb 2.
3
Comparison of efficacy and safety among axitinib, sunitinib, and sorafenib as neoadjuvant therapy for renal cell carcinoma: a retrospective study.阿昔替尼、舒尼替尼和索拉非尼作为肾细胞癌新辅助治疗的疗效和安全性比较：一项回顾性研究
Cancer Commun (Lond). 2019 Oct 11;39(1):56. doi: 10.1186/s40880-019-0405-5.
4
Efficacy of axitinib in patients with metastatic renal cell carcinoma refractory to nivolumab therapy.阿昔替尼在对纳武单抗治疗难治的转移性肾细胞癌患者中的疗效。
Jpn J Clin Oncol. 2019 Jun 1;49(6):576-580. doi: 10.1093/jjco/hyz040.
5
Successful sorafenib treatment for metastatic renal cell carcinoma in a case with chronic renal failure.索拉非尼成功治疗一例慢性肾衰竭转移性肾细胞癌
Eur Urol. 2009 Apr;55(4):986-8; quiz 988. doi: 10.1016/j.eururo.2008.10.027. Epub 2008 Oct 23.
6
Comparison of axitinib and sunitinib as first-line therapies for metastatic renal cell carcinoma: a real-world multicenter analysis.阿昔替尼与舒尼替尼作为转移性肾细胞癌一线治疗的比较：一项真实世界多中心分析。
Med Oncol. 2018 Nov 24;36(1):6. doi: 10.1007/s12032-018-1231-3.
7
[Treatment Outcome of Axitinib for Metastatic Renal-Cell Carcinoma Patients].阿昔替尼治疗转移性肾细胞癌患者的疗效
Hinyokika Kiyo. 2018 Sep;64(9):353-358. doi: 10.14989/ActaUrolJap_64_9_353.
8
Oncological outcomes of a multicenter cohort treated with axitinib for metastatic renal cell carcinoma.多中心队列中接受阿昔替尼治疗的转移性肾细胞癌的肿瘤学结局。
Cancer Sci. 2020 Jul;111(7):2460-2471. doi: 10.1111/cas.14449. Epub 2020 Jun 12.
9
Validation of the IMDC Prognostic Model in Patients With Metastatic Renal-Cell Carcinoma Treated With First-Line Axitinib: A Multicenter Retrospective Study.多中心回顾性研究：一线阿昔替尼治疗转移性肾细胞癌患者中 IMDC 预后模型的验证。
Clin Genitourin Cancer. 2019 Oct;17(5):e1080-e1089. doi: 10.1016/j.clgc.2019.07.006. Epub 2019 Jul 20.
10
Successful sunitinib treatment of metastatic renal cell carcinoma in a patient with end stage renal disease on hemodialysis.舒尼替尼成功治疗一名接受血液透析的终末期肾病患者的转移性肾细胞癌。
Anticancer Drugs. 2009 Oct;20(9):848-9. doi: 10.1097/CAD.0b013e32832fffc7.

引用本文的文献

1
Combination Therapy of Pembrolizumab plus Axitinib for a Patient on Hemodialysis with Metastatic Renal Cell Carcinoma: A Case Report.帕博利珠单抗联合阿昔替尼治疗一名接受血液透析的转移性肾细胞癌患者：病例报告
Case Rep Oncol. 2021 Oct 22;14(3):1522-1529. doi: 10.1159/000519855. eCollection 2021 Sep-Dec.
2
Renal toxicity of targeted therapies for renal cell carcinoma in patients with normal and impaired kidney function.针对肾功能正常和受损患者的肾癌的靶向治疗的肾毒性。
Cancer Chemother Pharmacol. 2021 Jun;87(6):723-742. doi: 10.1007/s00280-021-04260-y. Epub 2021 Mar 25.
3
Outcome of advanced renal cell carcinoma arising in end-stage renal disease: comparison with sporadic renal cell carcinoma.
终末期肾病相关的晚期肾细胞癌的预后：与散发性肾细胞癌的比较。
Clin Exp Nephrol. 2021 Jun;25(6):674-682. doi: 10.1007/s10157-021-02038-3. Epub 2021 Feb 27.
4
Genetic and epigenetic profiling indicates the proximal tubule origin of renal cancers in end-stage renal disease.遗传和表观遗传学分析表明，终末期肾病的肾细胞癌来源于近端肾小管。
Cancer Sci. 2020 Nov;111(11):4276-4287. doi: 10.1111/cas.14633. Epub 2020 Sep 18.